Investing
The company announced its expansion into a Silicon Valley-based production facility to develop its collaborative robotic system.
The company's revenue increased in Q2 of this year to $13.1 million compared to $10.7 million in the first quarter – still below the $18.3 million reported in Q2 2022.
The company will use the funds to grow its offerings, including its teletherapy platform, and expand its reach nationally.
Shawn Ellis, managing partner at Distributed Ventures, tells MobiHealthNews why and how the firm's recent raise will go toward advancing digital health.
The round brings the virtual care company's total raise to $205 million.
The company utilizes machine learning and patient data to deliver personalized medication management pertaining to polypharmacy.
It expects continued long-term growth in the demand for virtual care services post-pandemic.
The company will use the investment to fuel the expansion of Paradigm,its FDA-cleared, AI-enabled surgical navigation platform.
The multiple sclerosis-focused company will use the funds to speed up the company's commercialization efforts.
GenHealth AI, maker of what it calls a large medical model, and senior-focused startup K4Connnect also secured investment.